Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Silicon Laboratories    SLAB   US8269191024

Analysis summary4-Traders Strategies 

Silicon Laboratories : USD 49.9 as next target price

02/13/2013 | 10:25am
Opinion : Bullish above USD 42.7
Target price : USD 49.9
Stop loss: USD 40.5

The company shows strong fundamentals. Firstly, the high valuation of the group shows a great investors confidence in it because there are ready to pay a high price for the stock. Moreover, the consensus recently revised upward EPS estimates for this year and that let see a great potential for the security on the stock market.

From a technical viewpoint, the security is trading in a bullish trend in the short and the long term. Increasing moving averages let think there will be no reversal in the coming trading sessions. This growth should help to reach soon the USD 49.9 long term resistance.

A new bullish fluctuation could lead the security toward the USD 49.9 resistance. In consequence, investors can take a long position in Silicon Laboratories. A stop loss will be set under the short term support at USD 42.7.

Silicon Laboratories : Silicon Laboratories : USD 49.9 as next target price

© 2013

Disclaimer: is a website published by SURPERFORMANCE SAS. Surperformance or is not a registered broker-dealer nor a registered investment adviser. You understand that this web site and its content is furnished for your personal, noncommercial, informational purposes only, and that no mention of a particular security in this website constitutes a recommendation to buy, sell, or hold any other security, nor that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Surperformance and services will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. Information regarding trading and investment as provided by Surperformance professional is not tailored to the investment needs of any specific person. You acknowledge that you are responsible for your own financial decisions and should seek a registered financial agent depending on your own risk tolerance to advise you on your personal trading activities.

Financial Ratios

Size 2015e 2016e
Capitalization 2 095 M$ -
Entreprise Value (EV) 2 114 M$ 2 111 M$
Valuation 2015e 2016e
PER (Price / EPS) 51,0x 35,3x
Capitalization / Revenue 3,08x 2,84x
EV / Revenue 3,10x 2,86x
EV / EBITDA 15,6x 13,7x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 2,46x 2,21x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 17,2% 19,0%
operating Leverage (Delta EBIT / Delta Sales) 0,14x 2,37x
Net Margin (Net Profit / Revenue) 6,16% 8,29%
ROA (Net Profit / Asset) 6,65% 7,70%
ROE (Net Profit / Equities) 10,2% 11,4%
Rate of Dividend - -
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   2,06% 1,90%
Cash Flow / Sales (Taux d'autofinancement) 16,8% 16,6%
Capital Intensity (Assets / Sales) 0,93x 1,08x
Financial Leverage (Net Debt / EBITDA) 0,14x 0,11x
Income Statement Evolution
More Financials
EPS Revisions
Dynamic quotes